The ORMP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ORMP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ORMP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ORMP Detailed Price Forecast - CNN Money||View ORMP Detailed Summary - Google Finance|
|View ORMP Detailed Summary - Yahoo! Finance||View ORMP Stock Research & Analysis - Zacks.com|
|View ORMP Trends & Analysis - Trade-Ideas||View ORMP Major Holders - Barrons|
|View ORMP Call Transcripts - NASDAQ||View ORMP Breaking News & Analysis - Seeking Alpha|
|View ORMP Annual Report - CompanySpotlight.com||View ORMP OTC Short Report - OTCShortReport.com|
|View ORMP Fundamentals - TradeKing||View ORMP SEC Filings - Bar Chart|
|View Historical Prices for ORMP - The WSJ||View Performance/Total Return for ORMP - Morningstar|
|View the Analyst Estimates for ORMP - MarketWatch||View the Earnings History for ORMP - CNBC|
|View the ORMP Earnings - StockMarketWatch||View ORMP Buy or Sell Recommendations - MacroAxis|
|View the ORMP Bullish Patterns - American Bulls||View ORMP Short Pain Metrics - ShortPainBot.com|
|View ORMP Stock Mentions - StockTwits||View ORMP Stock Mentions - PennyStockTweets|
|View ORMP Stock Mentions - Twitter||View ORMP Investment Forum News - Investor Hub|
|View ORMP Stock Mentions - Yahoo! Message Board||View ORMP Stock Mentions - Seeking Alpha|
|View Insider Transactions for ORMP - SECform4.com||View Insider Transactions for ORMP - Insider Cow|
|View ORMP Major Holdings Summary - CNBC||View Insider Disclosure for ORMP - OTC Markets|
|View Insider Transactions for ORMP - Yahoo! Finance||View Institutional Holdings for ORMP - NASDAQ|
|View ORMP Stock Insight & Charts - FinViz.com||View ORMP Investment Charts - StockCharts.com|
|View ORMP Stock Overview & Charts - BarChart||View ORMP User Generated Charts - Trading View|
Oramed Pharmaceuticals' CEO Letter to Shareholders
Posted on Tuesday January 15, 2019
JERUSALEM , Jan. 15, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ) Dear Shareholders, We opened the year 2019 with the announcement of our receipt of a ...
Oramed Receives Additional $3 Million Milestone Payment from HTIT
Posted on Wednesday January 09, 2019
JERUSALEM, Jan. 9, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has received a milestone payment of $3 million from Hefei Tianhui Incubator of Technologies Co. Ltd. (HTIT). This milestone is part of a previously-announced license and investment agreement between Oramed and HTIT. "China is currently the largest single diabetes population in the world," stated Oramed CEO Nadav Kidron.
ORMP: Two Studies Ongoing for ORMD-0801 with Data Readouts in 2019…
Posted on Monday December 17, 2018
In Nov. 2018, Oramed Pharmaceuticals Inc. (ORMP) filed form 10-K with financial results for fiscal year 2018 that ended Aug. 31, 2018. The company reported revenues of $2.449 million, which was very similar to the $2.456 million reported in fiscal year 2017. Cost of revenues in fiscal year 2018 decreased to income of $86,000 compared to cost of $187,000 in fiscal year 2017.
Is Oramed Pharmaceuticals Inc’s (NASDAQ:ORMP) CEO Paid Enough Relative To Peers?
Posted on Tuesday November 27, 2018
Nadav Kidron has been the CEO of Oramed Pharmaceuticals Inc (NASDAQ:ORMP) since 2006. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we’ll consider growth